Jane Street Group, LLC Contrafect Corp Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.09 - $0.19 $6,615 - $13,966
73,510 Added 292.44%
98,647 $9,000
Q3 2022

Nov 14, 2022
BUY
$0.18 - $3.51 $4,524 - $88,230
25,137 New
25,137 $4,000
Q3 2020

Nov 17, 2020
SELL
$5.05 - $6.99 $78,628 - $108,834
-15,570 Closed
0 $0
Q2 2020

Aug 17, 2020
BUY
$4.69 - $7.81 $10,557 - $17,580
2,251 Added 16.9%
15,570 $99,000
Q1 2020

May 15, 2020
BUY
$5.5 - $12.3 $73,254 - $163,823
13,319 New
13,319 $76,000

Others Institutions Holding CFRX

# of Institutions
2
Shares Held
49.2K
Call Options Held
0
Put Options Held
0
View Full List

About CONTRAFECT Corp

CFRX Quotes by TradingView
  • Ticker CFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,332,700
  • Market Cap $1.18M
  • Description
  • ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...
More about CFRX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email